<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001251'>Ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> (AT) is a primary <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome characterized by oculocutaneous <z:hpo ids='HP_0001009'>telangiectasia</z:hpo>, <z:hpo ids='HP_0001251'>ataxia</z:hpo>, recurrent <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and development of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Epstein-Barr virus (EBV) is a B-cell lymphocytotropic virus which causes <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> and is also highly associated with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> and <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> in immunodeficient patients </plain></SENT>
<SENT sid="2" pm="."><plain>10 Japanese patients with AT were studied concerning the status of <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> by specific EBV serology, and reactivity of peripheral lymphocytes to EBV </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the AT patients had high EBV antibody titers of IgG to <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen (VCA) and early antigen (EA), while low titers of IgG to EBV-associated nuclear antigen (EBNA), compared with age and sex matched healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>However, significant differences were not apparent with antibodies to several other viruses between the AT patients and controls </plain></SENT>
<SENT sid="5" pm="."><plain>These antibody characteristics were thought to be that an activated <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> occurred in AT patients </plain></SENT>
<SENT sid="6" pm="."><plain>Then the lymphocytes were exposed to B95-8 strain EBV </plain></SENT>
<SENT sid="7" pm="."><plain>There was no significant differences in EBNA induction frequency at 24 hours prior to cellular DNA synthesis, between the AT and controls </plain></SENT>
<SENT sid="8" pm="."><plain>EBV-specific T cell killer function was very low as judged with the days of establishment of lymphoblastoid cells expressing EBNA on <z:hpo ids='HP_0000001'>all</z:hpo> cells after EBV exposure, when compared with the lymphocytes from controls </plain></SENT>
<SENT sid="9" pm="."><plain>These AT lymphoblastoid cells easily expressed EA and VCA by cultivation at lower temperature of 33 degrees C, 12-0-<z:chebi fb="0" ids="25456">tetradecanoyl</z:chebi>-<z:chebi fb="0" ids="45127">phorbol-13-acetate</z:chebi> treatment, 60Co irradiation and by P3HR-1 strain <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">Malignant transformation</z:e> with high colony forming efficiency in soft <z:chebi fb="2" ids="2511">agarose</z:chebi> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> formation in <z:mp ids='MP_0003815'>nude</z:mp> mice easily occurred with some of AT lymphoblastoid cells.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>